Interventions for treating post‐extraction bleeding
SK Nagraj, E Prashanti, H Aggarwal… - Cochrane Database …, 2018 - cochranelibrary.com
Background Post‐extraction bleeding (PEB) is a recognised, frequently encountered
complication in dental practice, which is defined as bleeding that continues beyond 8 to 12 …
complication in dental practice, which is defined as bleeding that continues beyond 8 to 12 …
Is alteration in single drug anticoagulant/antiplatelet regimen necessary in patients who need minor oral surgery? A systematic review with meta-analysis
TBB Calcia, HJR Oballe, AM de Oliveira Silva… - Clinical Oral …, 2021 - Springer
Objective This study aimed to systematically review literature about the effect of alteration of
the pharmacological regimen in adult patients using anticoagulants or antiplatelets who …
the pharmacological regimen in adult patients using anticoagulants or antiplatelets who …
Hemostatic agents for the management of bleeding risk associated with oral anticoagulant therapy following tooth extraction: a systematic review
M Nisi, E Carli, S Gennai, F Gulia, R Izzetti - Applied Sciences, 2022 - mdpi.com
The occurrence of bleeding following dental extraction is a relatively common complication.
A history of therapy with oral anticoagulants represents a major favoring factor, both in …
A history of therapy with oral anticoagulants represents a major favoring factor, both in …
Bleeding control measures during oral and maxillofacial surgical procedures: A systematic review
AR Akolkar, DG Kulkarni, KD Gangwani… - Journal of Dental …, 2017 - journals.lww.com
Surgical bleeding can be associated with an increased risk of morbidity and mortality across
all surgical areas. Thus, to avoid complications related to excessive bleeding, numerous …
all surgical areas. Thus, to avoid complications related to excessive bleeding, numerous …
Qualitative/chemical analyses of Ankaferd hemostat and its antioxidant content in synthetic gastric fluids
Introduction. Ankaferd hemostat (ABS) is the first topical haemostatic agent involving the red
blood cell‐fibrinogen interactions. The antihemorrhagic efficacy of ABS has been tested in …
blood cell‐fibrinogen interactions. The antihemorrhagic efficacy of ABS has been tested in …
[HTML][HTML] Functional and structural neurodegenerative activities of Ankaferd BloodStopper in a mouse sciatic nerve model
Traumatic and postoperative hemorrhages are life‑threatening complications. Ankaferd
BloodStopper (ABS) is a potent topical hemostatic agent to stop bleeding. However, ABS is …
BloodStopper (ABS) is a potent topical hemostatic agent to stop bleeding. However, ABS is …
Ankaferd hemostat: from molecules to medicine
R Ciftciler, IC Haznedaroğlu - Turkish Journal of Medical …, 2020 - journals.tubitak.gov.tr
Abstract Ankaferd hemostat (ABS; Ankaferd Blood Stopper®, İstanbul, Turkey) is a
hemostatic agent having an impact on red blood cell-fibrinogen interactions. The hemostatic …
hemostatic agent having an impact on red blood cell-fibrinogen interactions. The hemostatic …
A comparative evaluation of the effectiveness of chitosan-based dressing and conventional method of hemostasis in patients on oral antithrombotic therapy without …
S Seethamsetty, G Sarepally, A Sanober… - Journal of Pharmacy …, 2019 - journals.lww.com
Aims and Objectives: To assess the effectiveness of chitosan-based dressing after extraction
in individuals on antithrombotics, without modification of their treatment schedule. Materials …
in individuals on antithrombotics, without modification of their treatment schedule. Materials …
Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper
C Simsek, S Selek, M Koca… - SAGE Open …, 2017 - journals.sagepub.com
Ankaferd blood stopper is a standardized mixture of the plants Thymus vulgaris, Glycyrrhiza
glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica and has been used as a topical …
glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica and has been used as a topical …
Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)
R Ciftciler, AE Ciftciler, UY Malkan… - SAGE Open …, 2020 - journals.sagepub.com
Ankaferd hemostat (Ankaferd blood stopper [ABS], Istanbul, Turkey) is a hemostatic agent
affecting red blood cell-fibrinogen interactions. ABS has been traditionally used in Anatolia …
affecting red blood cell-fibrinogen interactions. ABS has been traditionally used in Anatolia …